Division of Nephrology

Mount Sinai Health System’s Division of Nephrology is at the forefront of kidney care and science with expert-led research, cutting-edge clinical innovations, and state of-the-art facilities. 

This specialty report highlights:

  • A clinical trial led by researchers at the Icahn School of Medicine at Mount Sinai to determine whether an anti-tumor necrosis factor-alpha (TNFa)-blocking antibody can extend the life of a transplanted kidney from a deceased donor
  • The Division’s launch of a new unit to research biomarkers for kidney disease and create risk prediction models
  • An investigation studying the link between exposure to particulate matter and albuminuria with systematic endothelial dysfunction and increased cardiovascular risk in first responders at the September 11th World Trade Center attacks in 2001
  • A comprehensive molecular assay portfolio being developed to monitor kidney function both before and after transplantation in an effort to detect fibrotic events before irreversible damage to the organ occurs